These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 12814776)

  • 21. Antibody Production and Th1-biased Response Induced by an Epitope Vaccine Composed of Cholera Toxin B Unit and Helicobacter pylori Lpp20 Epitopes.
    Li Y; Chen Z; Ye J; Ning L; Luo J; Zhang L; Jiang Y; Xi Y; Ning Y
    Helicobacter; 2016 Jun; 21(3):234-48. PubMed ID: 26332255
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protection against Helicobacter pylori infection in mongolian gerbil by intragastric or intramuscular administration of H. pylori multicomponent vaccine.
    Wu C; Shi Y; Guo H; Zou WY; Guo G; Xie QH; Mao XH; Tong WD; Zou QM
    Helicobacter; 2008 Jun; 13(3):191-9. PubMed ID: 18466394
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inflammation, immunity, and vaccine development for Helicobacter pylori.
    Müller A; Solnick JV
    Helicobacter; 2011 Sep; 16 Suppl 1():26-32. PubMed ID: 21896082
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alkyl hydroperoxide reductase: a candidate Helicobacter pylori vaccine.
    O'Riordan AA; Morales VA; Mulligan L; Faheem N; Windle HJ; Kelleher DP
    Vaccine; 2012 Jun; 30(26):3876-84. PubMed ID: 22512976
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness of vaccination with recombinant HpaA from Helicobacter pylori is influenced by host genetic background.
    Sutton P; Doidge C; Pinczower G; Wilson J; Harbour S; Swierczak A; Lee A
    FEMS Immunol Med Microbiol; 2007 Jul; 50(2):213-9. PubMed ID: 17567282
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral Immunization with a Multivalent Epitope-Based Vaccine, Based on NAP, Urease, HSP60, and HpaA, Provides Therapeutic Effect on
    Guo L; Yang H; Tang F; Yin R; Liu H; Gong X; Wei J; Zhang Y; Xu G; Liu K
    Front Cell Infect Microbiol; 2017; 7():349. PubMed ID: 28824883
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vaccinating against Helicobacter pylori in the developing world.
    Zawahir S; Czinn SJ; Nedrud JG; Blanchard TG
    Gut Microbes; 2013; 4(6):568-76. PubMed ID: 24253617
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protection Against
    Pan X; Ke H; Niu X; Li S; Lv J; Pan L
    Front Immunol; 2018; 9():1003. PubMed ID: 29867978
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral immunization against Helicobacter pylori--a future concept.
    Michetti P
    J Gastroenterol; 1998; 33 Suppl 10():66-8. PubMed ID: 9840022
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nongenetically modified Lactococcus lactis-adjuvanted vaccination enhanced innate immunity against Helicobacter pylori.
    Liu W; Tan Z; Liu H; Zeng Z; Luo S; Yang H; Zheng L; Xi T; Xing Y
    Helicobacter; 2017 Oct; 22(5):. PubMed ID: 28805287
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy, immunogenicity, and safety of a parenteral vaccine against Helicobacter pylori in healthy volunteers challenged with a Cag-positive strain: a randomised, placebo-controlled phase 1/2 study.
    Malfertheiner P; Selgrad M; Wex T; Romi B; Borgogni E; Spensieri F; Zedda L; Ruggiero P; Pancotto L; Censini S; Palla E; Kanesa-Thasan N; Scharschmidt B; Rappuoli R; Graham DY; Schiavetti F; Del Giudice G
    Lancet Gastroenterol Hepatol; 2018 Oct; 3(10):698-707. PubMed ID: 30042064
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunological features and efficacy of the reconstructed epitope vaccine CtUBE against Helicobacter pylori infection in BALB/c mice model.
    Guo L; Liu K; Zhao W; Li X; Li T; Tang F; Zhang R; Wu W; Xi T
    Appl Microbiol Biotechnol; 2013 Mar; 97(6):2367-78. PubMed ID: 23064457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathogenesis of Helicobacter pylori and perspectives of vaccine development against an emerging pathogen.
    Rappuoli R; Covacci A; Ghiara P; Telford J
    Behring Inst Mitt; 1994 Dec; (95):42-8. PubMed ID: 7755508
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunology and vaccines and nanovaccines for Helicobacter pylori infection.
    Milani M; Sharifi Y; Rahmati-Yamchi M; Somi MH; Akbarzadeh A
    Expert Rev Vaccines; 2015 Jun; 14(6):833-40. PubMed ID: 25645086
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral immunization with recombinant Lactococcus lactis delivering a multi-epitope antigen CTB-UE attenuates Helicobacter pylori infection in mice.
    Li X; Xing Y; Guo L; Lv X; Song H; Xi T
    Pathog Dis; 2014 Oct; 72(1):78-86. PubMed ID: 24687988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Promoting Immune Efficacy of the Oral Helicobacter pylori Vaccine by HP55/PBCA Nanoparticles against the Gastrointestinal Environment.
    Liu H; Liu W; Tan Z; Zeng Z; Yang H; Luo S; Wang L; Xi T; Xing Y
    Mol Pharm; 2018 Aug; 15(8):3177-3186. PubMed ID: 30011213
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention of Helicobacter pylori infection.
    Lee A
    Scand J Gastroenterol Suppl; 1996; 215():11-5. PubMed ID: 8722377
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunization with recombinant FliD confers protection against Helicobacter pylori infection in mice.
    Ghasemi A; Mohammad N; Mautner J; Karsabet MT; Ardjmand A; Moniri R
    Mol Immunol; 2018 Feb; 94():176-182. PubMed ID: 29324238
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The design of vaccines against Helicobacter pylori and their development.
    Del Giudice G; Covacci A; Telford JL; Montecucco C; Rappuoli R
    Annu Rev Immunol; 2001; 19():523-63. PubMed ID: 11244046
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of vaccines against Helicobacter pylori.
    Del Giudice G; Malfertheiner P; Rappuoli R
    Expert Rev Vaccines; 2009 Aug; 8(8):1037-49. PubMed ID: 19627186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.